Product Program year 2025 Source: CMS Open Payments

Biofire Respiratory Panel 2.1

Device Diagnostics

PDI 00815381020529

Open in the dashboard

General payments

$86,940

121 payments

Research payments

$113,012

8 payments

Through program year 2025, $86,940 in general payments and $113,012 in research payments were reported against Biofire Respiratory Panel 2.1 (Diagnostics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $10,598 31
2024 General $2,030 3
2024 Research $5,147 5
2023 General $74,312 87
2023 Research $107,865 3

Breakdown

Who paid General payments · program years 2023–2025
  1. BioFire Diagnostics, LLC $75,741 74 payments
  2. bioMerieux $11,199 47 payments
Top recipients General payments · program year 2025
  1. Daniel Feinstein Critical Care Medicine · Pinehurst, NC $7,885 74% · 8 payments
  2. Lorraine Glaves Pain Medicine · Astoria, NY $142 1% · 1 payment
  3. Amy Rowe Nurse Practitioner · Bronx, NY $142 1% · 1 payment
  4. Catherine Sharbaugh Nurse Practitioner, Family · Long Island City, NY $142 1% · 1 payment
  5. Lisa Marshall Nurse Practitioner, Family · Bronx, NY $142 1% · 1 payment

The top 5 of 24 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Critical Care Medicine Internal Medicine $7,885 74% · 1 practitioner
  2. Nurse Practitioner, Family Nurse Practitioner $1,704 16% · 12 practitioners
  3. Nurse Practitioner $426 4% · 3 practitioners
  4. Nurse Practitioner, Psychiatric/Mental Health Nurse Practitioner $142 1% · 1 practitioner
  5. Nurse Practitioner, Pediatrics Nurse Practitioner $142 1% · 1 practitioner

The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. North Carolina $7,885 74% · 1 recipient
  2. New York $2,556 24% · 18 recipients
  3. California $79 <1% · 1 recipient
  4. Colorado $62 <1% · 3 recipients
  5. Illinois $15 <1% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

121 general · 8 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record